Surface Oncology, Inc

(NASDAQ:SURF)

Latest On Surface Oncology, Inc (SURF):

Date/Time Type Description Signal Details
2023-05-04 17:05 ESTNewsSurface Oncology GAAP EPS of -$0.33 beats by $0.04N/A
2023-03-09 22:46 ESTNewsSurface Oncology GAAP EPS of -$0.35 misses by $0.03N/A
2022-11-02 23:35 ESTNewsSurface Oncology letting go of 20% of workforce as it pauses solid tumors candidateN/A
2022-08-03 11:16 ESTNewsSurface Oncology GAAP EPS of -$0.46 misses by $0.01N/A
2022-05-26 00:57 ESTNewsSurface Oncology: Neither Novartis, Nor GSK Or ARKG Is Able To Stop The DeclineN/A
2022-05-09 17:16 ESTNewsSurface Oncology GAAP EPS of $0.13 beats by $0.38, revenue of $30M beats by $17.42MN/A
2022-05-09 17:16 ESTNewsSurface Oncology gains after Q1 updates; cash runway extends to 2024N/A
2022-04-14 13:09 ESTNewsSurface Oncology begins phase 2 trials of SRF388 in liver, lung cancersN/A
2022-03-31 18:55 ESTNewsSurface Oncology stock rises with first patient dosed in GSK4381562 Phase 1 studyN/A
2022-03-02 23:47 ESTNewsSurface Oncology GAAP EPS of -$0.52 misses by $0.43, revenue of $0.15M misses by $16.18MN/A
2022-01-18 11:17 ESTNewsSurface Oncology: If Novartis, GlaxoSmithKline And ARK See Promise, So Do IN/A
2021-11-04 16:56 ESTNewsSurface Oncology EPS misses by $0.04, beats on revenueN/A
2021-10-25 04:40 ESTNewsSurface Oncology: Staying The CourseN/A
2021-10-04 13:43 ESTNewsSurface Oncology plans to initiate mid-stage SRF388 hepatocellular carcinoma studyN/A
2021-09-22 07:10 ESTNewsSurface Oncology climbs as AstraZeneca cancer trial data highlights anti-CD73 effectN/A
2021-08-13 21:29 ESTNewsSurface Oncology (SURF) Investor Presentation - SlideshowN/A
2021-08-05 13:51 ESTNewsSurface Oncology EPS misses by $0.09, misses on revenueN/A
2021-07-22 02:54 ESTNewsSurface Oncology shares rise after promising early-stage data from cancer studiesN/A
2021-07-22 02:21 ESTNewsSurface Oncology: A Diverse, But Early PipelineN/A
2021-05-05 23:53 ESTNewsSurface Oncology EPS beats by $0.04, beats on revenueN/A
2021-04-09 11:00 ESTNewsSurface Oncology's immunotherapy product candidates show promising data in tumor activityN/A
2021-03-31 08:54 ESTNewsSurface Oncology’s SRF617 gets FDA orphan drug statusN/A
2021-03-18 06:04 ESTNewsSurface Oncology is up; slated to feature at an upcoming Cathie Wood’s Ark Invest eventN/A
2021-03-13 07:53 ESTNewsSurface Oncology (SURF) Presents At Global Life Sciences Virtual Conference - SlideshowN/A
2021-03-10 12:23 ESTEarnings EstimateAn EPS average of -$0.27 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-10 12:23 ESTEarnings EstimateAn EPS average of -$1.57 is estimated for the 2022 year.Sell
2021-03-10 04:54 ESTFinancialsCompany financials have been released.Neutral
2021-03-10 00:07 ESTNewsSurface Oncology EPS beats by $1.31, beats on revenueN/A
2021-03-10 00:07 ESTNewsMerck and Surface Oncology partner for Keytruda combination in cancer trialN/A
2021-02-23 03:23 ESTNewsGoing Under The Covers With Surface OncologyN/A
2021-02-11 13:53 ESTNewsSurface Oncology promotes chief medical officer as new CEON/A
2020-12-23 09:04 ESTAnalyst RatingThe Analyst Target Price has increased from $14.8 to $15.4.Buy
2020-12-21 05:16 ESTAnalyst RatingThe Analyst Target Price has increased from $14 to $14.8.Buy
2020-12-18 13:05 ESTAnalyst RatingThe Analyst Target Price has increased from $13 to $14.Buy
2020-12-18 00:31 ESTNewsSurface Oncology shares rise 7% on licensing deal with GSK for immunotherapy programN/A
2020-12-10 01:08 ESTNewsSurface Oncology: Early Stage Cancer-Specific Company With Novel AssetsN/A
2020-11-26 21:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 12:52 ESTAnalyst RatingThe Analyst Target Price has increased from $11.8 to $13.Buy
2020-11-17 05:29 ESTAnalyst RatingThe Analyst Target Price has increased from $10.8 to $11.8.Buy
2020-11-13 10:22 ESTNewsSurface Oncology's lead cancer programs to advance to combination and expansion stages of early-stage studiesN/A
2020-11-12 13:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 05:45 ESTNewsSurface Oncology shares rise 13% on Fast Track tag for SRF388N/A
2020-11-11 13:04 ESTEarnings EstimateAn EPS average of -$0.37 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-11 01:26 ESTNewsSurface Oncology reports Q3 resultsN/A
2020-11-08 01:00 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:15 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 20:55 ESTInsider TradeJESSICA FEES has directly acquired 122 shares and currently holds 100,800 shares.Buy
2020-10-30 20:55 ESTInsider TradeJESSICA FEES has directly acquired 4,773 shares and currently holds 100,678 shares.Buy
2020-10-16 20:12 ESTInsider TradeROBERT W. ROSS has directly disposed of 4,000 shares and currently holds 101,000 shares.Sell
2020-10-12 16:21 ESTNewsSurface Oncology hires bankers to explore sale - StreetInsiderN/A

About Surface Oncology, Inc (SURF):

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops antibodies, including SRF231 inhibiting CD47; NZV930 inhibiting CD73; SRF617 inhibiting CD39; SRF388 targeting interleukin 27; SRF813 targeting CD112R; and SRF114 targeting the chemokine receptor CCR8. It also develops various earlier stage programs that targets other critical components of the tumor microenvironment, including regulatory T cells. The company has a strategic collaboration agreement with Novartis Institutes for Biomedical Research, Inc. for the development of cancer therapies; and GlaxoSmithKline to develop and commercialize specified antibodies, including SRF813 targeting CD112R. Surface Oncology, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

SURF Quotes by TradingView

See Advanced Chart

General

  • Name Surface Oncology, Inc
  • Symbol SURF
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 51
  • Fiscal Year EndDecember
  • IPO Date2018-04-19
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.surfaceoncology.com
View More

Valuation

  • Trailing PE 5.57
  • Price/Sales (Trailing 12 Mt.) 2.75
  • Price/Book (Most Recent Quarter) 2.44
  • Enterprise Value Revenue 2.02
  • Enterprise Value EBITDA 4.02
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.45
  • Next Year EPS Estimate -$1.55
  • Next Quarter EPS Estimate $0.23
  • Profit Margin 47%
  • Operating Margin 50%
  • Return on Assets 23%
  • Return on Equity 56%
  • Revenue 126.16 million
  • Earnings Per Share $1.57
  • Revenue Per Share $3.55
  • Gross Profit 86.34 million
  • Quarterly Earnings Growth 19847.6%
View More

Highlights

  • Market Capitalization 363.87 million
  • EBITDA 64.46 million
  • Analyst Target Price $15.4
  • Book Value Per Share $3.83
View More

Share Statistics

  • Shares Outstanding 41.73 million
  • Shares Float 30.93 million
  • % Held by Insiders 165%
  • % Held by Institutions 66.19%
  • Shares Short 2.48 million
  • Shares Short Prior Month 1.63 million
  • Short Ratio 2.01
  • Short % of Float 8%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 1.99
  • 52 Week High $14.4
  • 52 Week Low $1.5
  • 50 Day Moving Average 9.74
  • 200 Day Moving Average 8.96
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Surface Oncology, Inc (SURF) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Surface Oncology, Inc (SURF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$87.57 million$1.81$0.36406.29%
2020-09-302020-11-10$N/A-$0.39-$0.401.89%
2020-06-302020-08-11$N/A-$0.44-$0.5113.73%
2020-03-312020-05-12$38.59 million$0.74$0.79-6.33%
2019-12-312020-03-10$439000-$0.57-$0.570%
2019-09-302019-11-12$344000-$0.61-$0.58-5.77%
2019-06-302019-08-07$143000-$0.64-$0.61-5.49%
2019-03-312019-05-09$14.43 million-$0.15-$0.4768.31%
2018-12-312019-03-07$9.76 million-$0.17-$0.6774.75%
2018-09-302018-11-13$1.73 million-$0.62-$0.688.82%
2018-06-302018-08-14$2.43 million-$0.73-$0.763.31%
2018-03-312018-05-29$45.5 million$1.05$7.43-85.87%

Surface Oncology, Inc (SURF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Surface Oncology, Inc (SURF) Chart:

Surface Oncology, Inc (SURF) News:

Below you will find a list of latest news for Surface Oncology, Inc (SURF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Surface Oncology, Inc (SURF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest SURF Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST100$1.675
Jun 13, 2022 7:59 PM EST50$1.675
Jun 13, 2022 7:59 PM EST4$1.685
Jun 13, 2022 7:59 PM EST33$1.685
Jun 13, 2022 7:59 PM EST66$1.68

Surface Oncology, Inc (SURF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120036181/0001209191-20-036181-index.htm
2019-05-03UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1718108/000000000019008025/0000000000-19-008025-index.htm
2018-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000031506618001865/0000315066-18-001865-index.htm
2018-04-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000031506618001866/0000315066-18-001866-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000031506618002097/0000315066-18-002097-index.htm
2018-12-20SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000031506618002553/0000315066-18-002553-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000031506619001314/0000315066-19-001314-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000031506620001216/0000315066-20-001216-index.htm
2018-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000031898918000023/0000318989-18-000023-index.htm
2018-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000089924318019432/0000899243-18-019432-index.htm
2018-07-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000089924318020529/0000899243-18-020529-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000089924318021004/0000899243-18-021004-index.htm
2018-12-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000089924318031244/0000899243-18-031244-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000089924319000740/0000899243-19-000740-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000089924319000741/0000899243-19-000741-index.htm
2020-05-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000092189520001639/0000921895-20-001639-index.htm
2018-11-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000093583618000604/0000935836-18-000604-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000093583619000128/0000935836-19-000128-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000093583619000131/0000935836-19-000131-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000093583620000150/0000935836-20-000150-index.htm
2020-05-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000093583620000322/0000935836-20-000322-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000107261319000081/0001072613-19-000081-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000107261320000092/0001072613-20-000092-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000110465919006436/0001104659-19-006436-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000110465920010529/0001104659-20-010529-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000110465920020193/0001104659-20-020193-index.htm
2020-05-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000110465920067751/0001104659-20-067751-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1718108/000114420419008122/0001144204-19-008122-index.htm
2018-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312518173613/0001193125-18-173613-index.htm
2018-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312518350448/0001193125-18-350448-index.htm
2018-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312518352111/0001193125-18-352111-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312519003135/0001193125-19-003135-index.htm
2019-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312519027120/0001193125-19-027120-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312519038050/0001193125-19-038050-index.htm
2019-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1718108/000119312519067260/0001193125-19-067260-index.htm
2019-05-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1718108/000119312519130940/0001193125-19-130940-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1718108/000119312519138236/0001193125-19-138236-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312519168185/0001193125-19-168185-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312519250671/0001193125-19-250671-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312519263767/0001193125-19-263767-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312519293982/0001193125-19-293982-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312519299184/0001193125-19-299184-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312520005932/0001193125-20-005932-index.htm
2020-01-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312520015371/0001193125-20-015371-index.htm
2020-03-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1718108/000119312520067697/0001193125-20-067697-index.htm
2020-03-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312520075500/0001193125-20-075500-index.htm
2020-05-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1718108/000119312520150086/0001193125-20-150086-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312520150100/0001193125-20-150100-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000119312520167179/0001193125-20-167179-index.htm
2018-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919118025845/0001209191-18-025845-index.htm
2018-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919118025846/0001209191-18-025846-index.htm
2018-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919118025847/0001209191-18-025847-index.htm
2018-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919118025848/0001209191-18-025848-index.htm
2018-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919118025849/0001209191-18-025849-index.htm
2018-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919118025850/0001209191-18-025850-index.htm
2018-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919118025851/0001209191-18-025851-index.htm
2018-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919118025852/0001209191-18-025852-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119015868/0001209191-19-015868-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119015870/0001209191-19-015870-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119015872/0001209191-19-015872-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119015877/0001209191-19-015877-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119015891/0001209191-19-015891-index.htm
2019-04-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119021978/0001209191-19-021978-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119022728/0001209191-19-022728-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119026968/0001209191-19-026968-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119035096/0001209191-19-035096-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119035097/0001209191-19-035097-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119035100/0001209191-19-035100-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119035102/0001209191-19-035102-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119035103/0001209191-19-035103-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119035104/0001209191-19-035104-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119040466/0001209191-19-040466-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119040468/0001209191-19-040468-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119040469/0001209191-19-040469-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119040470/0001209191-19-040470-index.htm
2019-09-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119050314/0001209191-19-050314-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119052180/0001209191-19-052180-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119052192/0001209191-19-052192-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119052199/0001209191-19-052199-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119052209/0001209191-19-052209-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919119052219/0001209191-19-052219-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120006844/0001209191-20-006844-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120006845/0001209191-20-006845-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120006846/0001209191-20-006846-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120006847/0001209191-20-006847-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120006855/0001209191-20-006855-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120006856/0001209191-20-006856-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120007470/0001209191-20-007470-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120015072/0001209191-20-015072-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120031786/0001209191-20-031786-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120036175/0001209191-20-036175-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120036176/0001209191-20-036176-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120036177/0001209191-20-036177-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120036178/0001209191-20-036178-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120036179/0001209191-20-036179-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120036180/0001209191-20-036180-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120036181/0001209191-20-036181-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120055191/0001209191-20-055191-index.htm
2020-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000120919120056365/0001209191-20-056365-index.htm
2018-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459018014527/0001564590-18-014527-index.htm
2018-05-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1718108/000156459018014529/0001564590-18-014529-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459018021569/0001564590-18-021569-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1718108/000156459018021570/0001564590-18-021570-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459018029103/0001564590-18-029103-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1718108/000156459018029110/0001564590-18-029110-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459019006767/0001564590-19-006767-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1718108/000156459019006783/0001564590-19-006783-index.htm
2019-04-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1718108/000156459019012062/0001564590-19-012062-index.htm
2019-04-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1718108/000156459019012063/0001564590-19-012063-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459019017525/0001564590-19-017525-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1718108/000156459019017527/0001564590-19-017527-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459019029606/0001564590-19-029606-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1718108/000156459019029612/0001564590-19-029612-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459019042462/0001564590-19-042462-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1718108/000156459019042483/0001564590-19-042483-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459020009510/0001564590-20-009510-index.htm
2020-03-1010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1718108/000156459020009521/0001564590-20-009521-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1718108/000156459020017796/0001564590-20-017796-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1718108/000156459020017800/0001564590-20-017800-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459020018288/0001564590-20-018288-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459020024463/0001564590-20-024463-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1718108/000156459020024469/0001564590-20-024469-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459020025265/0001564590-20-025265-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459020025639/0001564590-20-025639-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000156459020026253/0001564590-20-026253-index.htm
2020-05-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1718108/000156459020027300/0001564590-20-027300-index.htm
2020-05-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000156761920011344/0001567619-20-011344-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000156761920016420/0001567619-20-016420-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000162828020012386/0001628280-20-012386-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1718108/000162828020012388/0001628280-20-012388-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1718108/000171810820000003/0001718108-20-000003-index.htm
2018-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1718108/000173717418000002/0001737174-18-000002-index.htm
2019-05-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1718108/999999999519001053/9999999995-19-001053-index.htm
2018-11-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1718108/999999999718009233/9999999997-18-009233-index.htm
2020-02-07SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1718108/999999999720000603/9999999997-20-000603-index.htm
2020-02-27SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1718108/999999999720001043/9999999997-20-001043-index.htm

Surface Oncology, Inc (SURF) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Surface Oncology, Inc (SURF). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 165%
Institutional Ownership: 6619%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-10-28JESSICA FEESOfficerBuy4,773.004.1419,741.13100,678.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120056365/0001209191-20-056365-index.htm
2020-10-28JESSICA FEESOfficerBuy122.004.27520.94100,800.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120056365/0001209191-20-056365-index.htm
2020-10-14ROBERT W. ROSSChief Medical OfficerSell4,000.0010.0540,200.00101,000.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120055191/0001209191-20-055191-index.htm
2020-02-03ROBERT W. ROSSChief Medical OfficerBuy80,000.00105,000.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120006846/0001209191-20-006846-index.htm
2019-01-04ROBERT W. ROSSChief Medical OfficerBuy25,000.004.14103,400.0025,000.00https://www.sec.gov/Archives/edgar/data/1718108/000089924319000741/0000899243-19-000741-index.htm
2020-02-03Jeff GoaterChief Executive OfficerBuy257,000.00257,000.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120006844/0001209191-20-006844-index.htm
2020-02-05Jeff GoaterChief Executive OfficerBuy5,000.003.2316,150.00262,000.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120007470/0001209191-20-007470-index.htm
2020-05-20New Enterprise Associates 14, L.P.10% Share HolderSell420,000.003.661,535,562.002,892,877.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120031786/0001209191-20-031786-index.htm
2018-04-23Anthony A. Jr. Florence10% Share HolderBuy133,333.0015.001,999,995.003,312,877.00https://www.sec.gov/Archives/edgar/data/1718108/000120919118025847/0001209191-18-025847-index.htm
2018-04-23DAVID M MOTT10% Share HolderBuy133,333.0015.001,999,995.003,312,877.00https://www.sec.gov/Archives/edgar/data/1718108/000120919118025849/0001209191-18-025849-index.htm
2018-04-23FOREST BASKETT10% Share HolderBuy133,333.0015.001,999,995.003,312,877.00https://www.sec.gov/Archives/edgar/data/1718108/000120919118025846/0001209191-18-025846-index.htm
2018-04-23PATRICK J KERINS10% Share HolderBuy133,333.0015.001,999,995.003,312,877.00https://www.sec.gov/Archives/edgar/data/1718108/000120919118025848/0001209191-18-025848-index.htm
2018-04-23PETER J BARRIS10% Share HolderBuy133,333.0015.001,999,995.003,312,877.00https://www.sec.gov/Archives/edgar/data/1718108/000120919118025845/0001209191-18-025845-index.htm
2018-04-23Peter W. Sonsini10% Share HolderBuy133,333.0015.001,999,995.003,312,877.00https://www.sec.gov/Archives/edgar/data/1718108/000120919118025851/0001209191-18-025851-index.htm
2018-04-23Ravi Viswanathan10% Share HolderBuy133,333.0015.001,999,995.003,312,877.00https://www.sec.gov/Archives/edgar/data/1718108/000120919118025852/0001209191-18-025852-index.htm
2018-04-23SCOTT D SANDELL10% Share HolderBuy133,333.0015.001,999,995.003,312,877.00https://www.sec.gov/Archives/edgar/data/1718108/000120919118025850/0001209191-18-025850-index.htm
2020-09-01EcoR1 Capital, LLC10% Share HolderSell332,780.007.142,376,681.484,701,081.00https://www.sec.gov/Archives/edgar/data/1718108/000156761920016420/0001567619-20-016420-index.htm
2019-01-04JESSICA FEESOfficerBuy1,818.000.35639.9447,722.00https://www.sec.gov/Archives/edgar/data/1718108/000089924319000740/0000899243-19-000740-index.htm
2019-01-04JESSICA FEESOfficerBuy455.004.141,881.8848,177.00https://www.sec.gov/Archives/edgar/data/1718108/000089924319000740/0000899243-19-000740-index.htm
2019-04-01JESSICA FEESOfficerBuy2,728.000.35960.2650,905.00https://www.sec.gov/Archives/edgar/data/1718108/000120919119022728/0001209191-19-022728-index.htm
2020-02-03Liisa I NogeloChief Legal OfficerBuy80,000.0080,000.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120006856/0001209191-20-006856-index.htm
2020-02-03Vito J. PalombellaChief Scientific OfficerBuy80,000.0080,000.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120006855/0001209191-20-006855-index.htm
2020-02-03Wendy DwyerChief Business OfficerBuy80,000.0080,000.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120006847/0001209191-20-006847-index.htm
2020-02-28Wendy DwyerChief Business OfficerBuy5,000.001.708,500.0085,000.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120015072/0001209191-20-015072-index.htm
2020-02-03JESSICA FEESOfficerBuy45,000.0095,905.00https://www.sec.gov/Archives/edgar/data/1718108/000120919120006845/0001209191-20-006845-index.htm